Less Ads, More Data, More Tools Register for FREE

Pin to quick picksABC.L Regulatory News (ABC)

  • There is currently no data for ABC

Director/PDMR Shareholding

9 Dec 2016 14:56

RNS Number : 4852R
ABCAM Plc
09 December 2016
 

For immediate release

9 December 2016

ABCAM PLC

("Abcam" or "the Company")

Non-Executive Director Remuneration

Cambridge, UK: Abcam plc (AIM: ABC), a global leader in the supply of life science research tools, has been notified that, each Non-Executive Director ("NED") purchased ordinary shares of 0.2 pence each in the Company ("Shares") on 8 December 2016 at a price of 785.8803 pence per share pursuant to individual fee agreements entered into by the NEDs with the Company on 15 October 2015 ("Fee Agreements") under which the NEDs agreed to receive part of their fees delivered as a fixed number of Shares.

 

Under the Fee Agreements, it was agreed that one third of the NEDs' initial total fees for Abcam's financial year ending 30 June 2016 would be delivered as Shares after deductions for PAYE and National Insurance following the announcement of the preliminary results for the year on 12 September 2016. As previously announced, a fixed number of Shares were calculated for each NED by dividing one third of the total fees by the average share price of £5.95 (being the average share price for the ten dealing days following the announcement of Abcam's preliminary results for the year ended 30 June 2015). A final reconciliation has now been completed and in order to satisfy the agreed one third of their total fee in Shares, the additional Shares detailed below have been purchased.

Details of the net number of Shares purchased and the total interest in the Company of each NED after the share purchase are set out below:

 

Non-Executive Director

Net number of Shares purchased

Total holding of Shares

Louise Patten

431

38,887

Mara Aspinall

298

1,048

Murray Hennessy

504

37,323

Susan Harris

428

1,615

 

Each of the NEDs has committed not to transfer or sell the Shares during the term of their Non-Executive directorship.

Michael Ross and Anthony Martin, who were Non-Executive Directors of the Company until 31 October 2016, received 78 and 220 Shares respectively 8 December 2016 in respect of their fees for Abcam's financial year ending 30 June 2016

For further information please contact:

Abcam

+ 44 (0) 1223 696 000

Suzanne Smith, Company Secretary

 

J.P.Morgan Cazenove - Nominated Adviser & Corporate Broker

+ 44 (0) 20 7742 4000

James Mitford / Chris Cargill

FTI Consulting

+ 44 (0) 20 3727 1000

Ben Atwell / Brett Pollard / Natalie Garland-Collins

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Louise Patten

2

Reason for the notification

a)

Position/status

Senior Independent Director

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Abcam plc

b)

Legal Entity Identifier

N/A

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 0.2 pence each

 

 

 

GB00B6774699

b)

Nature of the transaction

Purchase of shares pursuant to individual fee arrangements

c)

Currency

GBP

d)

Price(s) and volume(s)

Price(s)

Volume(s)

7.858803

431

e)

Aggregated information

- Aggregated volume

- Price

- Aggregated total

 

431

7.858803

3,387.14

f)

Date of the transaction

8 December 2016

g)

Place of the transaction

London Stock Exchange, AIM

 

 

 

 

 

 

 

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Mara Aspinall

2

Reason for the notification

a)

Position/status

Non-Executive Director

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Abcam plc

b)

Legal Entity Identifier

N/A

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 0.2 pence each

 

 

 

GB00B6774699

b)

Nature of the transaction

Purchase of shares pursuant to individual fee arrangements

c)

Currency

GBP

d)

Price(s) and volume(s)

Price(s)

Volume(s)

7.858803

298

e)

Aggregated information

- Aggregated volume

- Price

- Aggregated total

 

298

7.858803

2,341.92

f)

Date of the transaction

8 December 2016

g)

Place of the transaction

London Stock Exchange, AIM

 

 

 

 

 

 

 

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Murray Hennessy

2

Reason for the notification

a)

Position/status

Chairman

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Abcam plc

b)

Legal Entity Identifier

N/A

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 0.2 pence each

 

 

 

GB00B6774699

b)

Nature of the transaction

Purchase of shares pursuant to individual fee arrangements

c)

Currency

GBP

d)

Price(s) and volume(s)

Price(s)

Volume(s)

7.858803

504

e)

Aggregated information

- Aggregated volume

- Price

- Aggregated total

 

504

7.858803

3,960.83

f)

Date of the transaction

8 December 2016

g)

Place of the transaction

London Stock Exchange, AIM

 

 

 

 

 

 

 

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Susan Harris

2

Reason for the notification

a)

Position/status

Non-Executive Director

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Abcam plc

b)

Legal Entity Identifier

N/A

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 0.2 pence each

 

 

 

GB00B6774699

b)

Nature of the transaction

Purchase of shares pursuant to individual fee arrangements

c)

Currency

GBP

d)

Price(s) and volume(s)

Price(s)

Volume(s)

7.858803

428

e)

Aggregated information

- Aggregated volume

- Price

- Aggregated total

 

428

7.858803

3,363.56

f)

Date of the transaction

8 December 2016

g)

Place of the transaction

London Stock Exchange, AIM

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHZKLFBQLFEFBX
Date   Source Headline
1st Oct 20204:41 pmRNSTotal Voting Rights
25th Sep 20201:33 pmRNSDirector/PDMR Shareholding
18th Sep 20202:19 pmRNSBlock listing Interim Review
18th Sep 20207:54 amRNSDirector/PDMR Shareholding
14th Sep 20207:00 amRNSFull Year Results 2020
11th Sep 202010:34 amRNSNotice of Results
1st Sep 20207:52 amRNSTotal Voting Rights
4th Aug 202012:57 pmRNSTotal Voting Rights
23rd Jul 20207:00 amRNSChange of Adviser
23rd Jul 20207:00 amRNSFull Year Trading Update
2nd Jul 202010:11 amRNSTotal Voting Rights
16th Jun 202012:00 pmRNSDirectorate Change
1st Jun 20209:29 amRNSTotal Voting Rights
11th May 202011:00 amRNSStatement re Update on 2019 AGM Resolution Vote
1st May 202012:24 pmRNSTotal Voting Rights
22nd Apr 202010:11 amRNSHolding(s) in Company
21st Apr 20207:26 amRNSDirector/PDMR Shareholding
20th Apr 202010:19 amRNSHolding(s) in Company
20th Apr 20207:00 amRNSCOVID-19 Update
14th Apr 202010:07 amRNSHolding(s) in Company
9th Apr 20205:33 pmRNSIssue of Shares
2nd Apr 20209:50 amRNSTotal Voting Rights
27th Mar 20203:37 pmRNSHolding(s) in Company
9th Mar 20207:00 amRNSInterim results for 6 months ended 31 Dec 2019
4th Mar 20207:00 amRNSAcquisition of Marker Gene Technologies
2nd Mar 20203:43 pmRNSTotal Voting Rights
2nd Mar 20208:00 amRNSBlock listing Interim Review
4th Feb 202010:49 amRNSTotal Voting Rights
30th Jan 20207:00 amRNSAbcam expands cell engineering capabilities
28th Jan 20202:31 pmRNSHolding(s) in Company
28th Jan 20202:29 pmRNSDirector/PDMR Shareholding
14th Jan 20207:00 amRNSAppointment of Chief Financial Officer
10th Jan 20207:00 amRNSHalf Year Trading Update
2nd Jan 20209:45 amRNSTotal Voting Rights
2nd Jan 20207:00 amRNSTransaction complete between Abcam and Expedeon
19th Dec 201910:05 amRNSHolding(s) in Company
4th Dec 20193:37 pmRNSHolding(s) in Company
2nd Dec 20193:25 pmRNSDirector/PDMR Shareholding
2nd Dec 20199:30 amRNSTotal Voting Rights
21st Nov 201911:42 amRNSHolding(s) in Company
14th Nov 20197:00 amRNSAbcam Capital Markets Event
13th Nov 20194:45 pmRNSResult of AGM
11th Nov 20197:00 amRNSAbcam to acquire proteomics & immunology business
6th Nov 20199:06 amRNSDirector/PDMR Shareholding
1st Nov 201910:55 amRNSTotal Voting Rights
2nd Oct 20194:28 pmRNSHolding(s) in Company
2nd Oct 20191:49 pmRNSDirector/PDMR Shareholding
1st Oct 20192:22 pmRNSTotal Voting Rights
30th Sep 20191:35 pmRNSAnnual Financial Report
26th Sep 20192:30 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.